Dyne Therapeutics, Inc.
DYN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818794
In the last 90 days, Dyne Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 245 institutions reported holding it in 13F filings for Q2 2026, worth $4.23B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Dyne Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- −4 vs. Q2 2023
- Shares held
- 59.9M
- +699.0K (+1.2%) vs. Q2 2023
- Total value
- $536.6M
- −$129.3M (−19.4%) vs. Q2 2023
- New holders
- 10
- 47 more added
- Sold out
- 14
- 32 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DYN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 245 | $4.23B |
| Q1 2026 | 228 | $3.40B |
| Q4 2025 | 233 | $3.48B |
| Q3 2025 | 207 | $1.97B |
| Q2 2025 | 198 | $1.22B |
| Q1 2025 | 205 | $1.29B |
| Q4 2024 | 200 | $2.63B |
| Q3 2024 | 200 | $4.03B |
| Q2 2024 | 193 | $3.92B |
| Q1 2024 | 169 | $2.71B |
| Q4 2023 | 124 | $930.0M |
| Q3 2023 | 114 | $536.6M |
| Q2 2023 | 118 | $665.9M |
| Q1 2023 | 127 | $628.7M |
| Q4 2022 | 113 | $576.2M |
| Q3 2022 | 102 | $565.8M |
| Q2 2022 | 90 | $320.7M |
| Q1 2022 | 94 | $456.6M |
| Q4 2021 | 93 | $568.3M |
| Q3 2021 | 83 | $572.8M |
| Q2 2021 | 76 | $753.4M |
| Q1 2021 | 75 | $533.3M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Dyne Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameritas Investment Partners, Inc. | 3,510 | $31.4K | 0.00% | 00.0% | Unchanged |
| Quarry LP | 3,200 | $28.7K | 0.02% | +3,200 | New |
| Metropolitan Life Insurance Co | 2,376 | $21.3K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 1,558 | $14.0K | 0.00% | +794+103.9% | Added |
| Truvestments Capital LLC | 464 | $4.16K | 0.00% | 00.0% | Unchanged |
| Spire Wealth Management | 400 | $3.58K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 210 | $2.00K | 0.00% | 00.0% | Unchanged |
| Comerica Bank | 175 | $1.57K | 0.00% | +175 | New |
| Lindbrook Capital, LLC | 136 | $1.22K | 0.00% | +33+32.0% | Added |
| Washington Trust Advisors, Inc. | 125 | $1.12K | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 111 | $995 | 0.00% | −103−48.1% | Reduced |
| EverSource Wealth Advisors, LLC | 90 | $806 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 61 | $547 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 35 | $314 | 0.00% | −10−22.2% | Reduced |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −798,701−100.0% | Sold out |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −195,600−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −119,918−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −82,400−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −62,000−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −39,796−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −34,063−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −27,380−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −24,279−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −13,300−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −2,700−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −43−100.0% | Sold out |